Monitoring of pneumocystis jirovecii pneumonia by specialized pro-resolving mediators

Marc Dubourdeau (Toulouse, France), Marc Dubourdeau, Vincent Baillif, Gerald Chene, Charlotte Guigne, Estelle Wanecq, Emeline Van Goethem, Marine Le Bouar, Antoine Berry, Xavier Iriart

Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Session: Microbiological issues and translational research in respiratory infections
Session type: Thematic Poster
Number: 2627
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marc Dubourdeau (Toulouse, France), Marc Dubourdeau, Vincent Baillif, Gerald Chene, Charlotte Guigne, Estelle Wanecq, Emeline Van Goethem, Marine Le Bouar, Antoine Berry, Xavier Iriart. Monitoring of pneumocystis jirovecii pneumonia by specialized pro-resolving mediators. Eur Respir J 2016; 48: Suppl. 60, 2627

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pneumocystis pneumonia in the non-HIV population
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013

Prognosis of pneumocystis jirovecii pneumonia in non-HIV patients
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013

Biomarkers for oxidative stress in patients with community-acquired pneumonia
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015



Exacerbations and pneumonia in bronchiectasis: Clinical and microbiological characterization
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015

Cytokines and local inflammation in pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 376s
Year: 2005

Pulmonary embolism or Pneumocystis jiroveci pneumonia?
Source: ISSN=ISSN 1810-6838, ISBN=, page=83
Year: 2006

Clinical and radiological features of pneumocystis pneumonia in immunocompromised non-HIV patients
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Role of pneumocystis jiroveci in interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 557s
Year: 2004

Evaluation of β-D-glucan, LD and KL-6 in the diagnosis and monitoring of Pneumocystis carinii pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 336s
Year: 2003

Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Modern etiology of severe community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Compared efficacies of lung delivery using two nebulizers in the prophylaxis against pneumocystis carinii pneumonia
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Biomarkers in community-acquired pneumonia: still searching for the one
Source: Eur Respir J, 53 (2) 1802469; 10.1183/13993003.02469-2018
Year: 2019



Cavitary bacterial lung infections – Predictive factors and outcomes
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Outbreak of pneumocystis jiroveci pneumonia among renal transplant patients
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013


Features of pneumonia diagnostics in burn trauma patients
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014



The results of immunotherapy of community acquired pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013

Lymphopoenia and pneumocystis jiroveci (PCP) prophylaxis experience in non-specific interstitial pneumonitis (NSIP)
Source: International Congress 2014 – ILDs 2
Year: 2014

Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

Clinical analysis of 32 cases of biopsy-proven secondary organizing pneumonia following community-acquired pneumonia
Source: International Congress 2014 – ILDs 4
Year: 2014